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With the anticipated "go live" for the
PHAMIS LastWord system, it is
important to stress patient record
security. Individual identification
numbers and personal passwords
should NOT be disclosed to anyone.
As the PHAMIS LastWord system is
integrated into our offices, we, as
physicians, will be responsible for the
actions of our staff members. The
system will be able to capture every
access to a patient's chart. Random
audits are planned periodically.
Much of our time over the past month
has been devoted to managed care.
We continue to work with our
consultant, Dan Grauman of The
Raleigh Group, to develop a managed
health care plan. As we learn more of
the national initiatives from
Washington, it seems to us that a local
community level based plan would be
the appropriate response. Such a plan
should focus on the enrollees and be
not-for-profit. We must strive for a
quality driven, locally controlled, and
physician directed plan; however, we
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also need our hospital management to
bridge our organization into a viable
PHO to meet the requirements for
federal certification as a competitive
medical plan.
All health care professionals must
come together to deal with health care
reform and its realities. We must not
exist in a· vacuum but become part of
the solution or be its victim. We will
respond to a national initiative based
on our local community. The future of
health care is in the hands of the
people who design it.

It

Candio, M.D.

President, Medical Staff

Physician Assistance Program Now Available
The Medical Staff of Lehigh Valley
Hospital recognizes that a wide range
of problems in life can affect a
physician's health and well being, and,
at times, professional performance.
In fact, a recent study by the National
Institute for Occupational Health and
Safety reports that physicians, along
with other caregivers, may have a
higher than average risk of developing
debilitating personal problems.
Therefore, the Medical Staff has
established the Physician Assistance
Program to help members deal with
personal problems before they affect
health, family life or professional
effectiveness.
The Physician Assistance Program is a
confidential (and if so desired,
anonymous), professional counseling
and referral service available to active
members of the Medical Staff of
Lehigh Valley Hospital and their
dependents.
This service is provided through an
agreement with The Counseling
Program of Pennsylvania Hospital.
The Counseling Program - Lehigh
Valley Division (TCP) operates the
Lehigh Valley Hospital's Employee
Assistance Program (EAP) and has
been involved with over 1,600
employees since 1985.
The Physician Assistance Program
offers physicians and their families
counseling services for a wide range of
personal problems·-- anything that can
turn stress into distress -- including
marital or relationship difficulties,
depression and anxiety, alcohol or drug

'I

abuse, family problems, or stress from
work or personal concerns.
Program users can choose from a
multi-disciplinary team assembled to
provide Physician Assistance Program
services. This team includes:

o Michael W. Kaufmann, M.D.,

Chairman, Department of Psychiatry,
Lehigh Valley Hospital
o John C. Turoczi, Ed.D., licensed
psychologist and member of the Allied
Health Professional Staff of Lehigh
Valley Hospital

o Gary Goodwin, M.A., licensed
psychologist and Senior Clinician at
The Counseling Program
o Linda Unser, R.N., Certified
)
Addictions Counselor and The
Counseling Program's drug and alcohol
specialist
o Staff of The Counseling Program Pennsylvania Division (Philadelphia),
including board certified psychiatrists,
licensed psychologists, and licensed
social workers.
To use the Physician Assistance
Program during normal working hours,
telephone The Counseling Program's
office at (215) 433-8550 or 1-800-3278878, identify yourself ONLY as a
member of the Lehigh Valley
Hospital's Medical Staff (or a family
member), and ask to speak to the
Program Manager, Oliver Neith.
Please note that callers may remain
anonymous.
Continued on Page 3
Page 2

Continued from Page 2

Mr. Neith, or his designee, will
conduct a brief telephone interview,
offer a choice among the above listed
provider team members, and advise the
caller how to arrange an appointment.

Other professional staff of The
Counseling Program are available after
hours to respond to emergency
situations.
The number of visits will vary with the
nature and severity of the problem.
Up to five visits with Physician
Assistance Program providers are
available to Medical Staff members
(and their dependents) at no cost.

If there is a need for further service or

treatment, a referral may be made to a
private practitioner or community
resource, or the user may continue
with the original Physician Assistance
Program provider on a self-pay basis.

For more information, contact Oliver
Neith at The Counseling Program at
433-8550, or John W. Hart, Vice
President, Medical Staff Services at
402-8968, or any member of TROIKA.

The Center for Women's Medicine to Open
On Monday, May 10, The Center for·
Women's Medicine will open on the
first floor, West Wing, at 17th &
Chew. This wing will house the
resident practice (formerly in the
ground floor OB-GYN clinic), the
faculty practice, the administrative
offices, and the faculty offices.

After opening, as a courtesy to
patients, the hallway through the
Center will no longer be a
thoroughfare for staff or patients who
do not have business within the
Department of Obstetrics and
Gynecology. This means that
employees, medical staff, and patients
will need to find alternate routes to the
Pharmacy, Clinical Laboratory,
Medical Library, and the cafeteria, as
well as other administrative offices on
the first floor.

Patients. using the Center will be
directed to enter from the green
elevator and come directly into the
reception area/waiting room.
Anyone using Conference Room B is
asked to enter at the end of the 1m.ll
where the West Wing and Trexler
Wing meet by using the blue elevator
or steps to get to the first floor. This
will bring you into the Center at the
Administrative office area and will
eliminate traffic through the designated
ambulatory care area.
Your cooperation is appreciated.
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KePROKomer
be aware the KePRO will begin
Its 4th Scope of Work effective April
15. Quality Screens will be distributed
to all physicians' offices so they may
review the complete set of quality
screens to be utilized by KePRO. The
major differences in the process
include:
~lease

o Overall volume of cases to be

will be reduced. Sampling
will be based on a beneficia~v base
rather than provider specific ·random ·
sampling of cases. Once beneficiaries
~ selected for KePRO review, they
will remain under review for the rest
of their life.

re~ewed

o 100% of KePRO case review will

be conducted off site (i.e., not at the
hospital).

o There will be no quality of care

severity level assignments, no
calculations of weighted scores based
on quality review findings.
o KePRO is expected to conduct an
assessment of the adequacy of
documentation in the medical record
for every case review performed.

Pain Management Update
The Bard Ambulatory PCA Pumps will
be implementer! on Monday, May 3, at
both sites. Tb ··ump replaces the
current Bard f
,.,ump, and will be
used for both r
and epidural
therapy. Fifty-five pumps will be

available for use which should
eliminate the ongoing shortage.

Inadequate documentation may result ir
technical denials. This may result in
denial of payment to the hospital.

o KePRO will be performing pattern

analysis based on all Medicare claims
submitted and will have the capability
of utilizing that data in conducting their
review as well as individual case
review.
Their plan is to move to a continuous
quality improvement approach, and
they are required to meet with each
hospital in the Commonwealth of
Pennsylvania once a year to share and
feed back review findings specific to
the facility. They are interested in
identifying benchmark (best practice)
patterns of care as well as identifying
opportunities for improvement.
If you have any questions about
KePRO's 4th Scope of Work, or if you
do not receive a copy of the generic
quality screens in your office, please
call Susan Lawrence, Director,
Integrated Quality
Assessment/Resource Utilization ,
Management, at 402-2414.
.

This pump utilizes infusion bags
instead of syringes. The Pharmacy
will provide the medication in lOOcc
mini-bags. The pumps and tubing will
be stocked in SPD for distribution.
If you have any questions regarding

this issue, please contact Cassie
Snyder, Coordinator, Pain
Management, by paging her on beeper

n2s;
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On April30, conversion will begin to

the PHAMIS LastWord patient care/
management/accounting system. About
eight days later' the ms system will be
replaced by the activated PHAMIS
PCMA system.
From today through activation,
physicians are requested to:

o Fill out the Face Sheet when

discharging (this helps the coders
immensely)

o Dictate Discharge Summaries ASAP

During the week of April-25-30, from
6 to 10 a.m., Medical Record
Department staff will be available in
the Medical Staff Lounge areas at 17th
& Chew and Cedar Crest & 1-78 to
assist physicians with attestation
completion.
Your cooperation in prompt record
complet;.on is appreciated. If you have
any questions or need further
assistance, please contact Rachel Allen,
Supervisor, Incomplete Chart Control,
at 402-8363.

o Sign attestations ASAP
o Check and complete medical

records DAILY from April 25 through
30

PHAMIS "Go Live" and PC Purchases
PHAMIS is scheduled to "Go Live" on
April30, 1993. A conversion process
will start at that time with PHAMIS
terminals available for use
approximately seven· days thereafter.

)

Many physicians' offices ·have
expressed interest in obtaining
computers for home and/or office use.
For your information, a copy of the
hospital's Vendor Comparison Matrix
is attached to this newsletter on pages
19-22. This chart is organized by
machine configuration available from
various vendors. The computers
indicated on this list will be compatible
with PHAMIS. Initial warranty period
is generally one year. After the
warranty, purchasers are responsible
for obtaining PC maintenance. The

Information Services Department has
been requested by the liS Physicians
Committee to provide PC maintenance
and personalized training services. It
will take Information Services six. to
nine months to determine what services
should be provided.
Additionally, physician refresher
classes for PHAMIS training will be
offered in April. For a list of dates,
times and locations, please refer to
page 18 of this newsletter.
If you have any questions regarding
PHAMIS, please contact Debra
Kruszewski in Information Services at
400-1424.
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Metabolic Bone Disease Program Established
The Metabolic Bone Disease Proaram
has been established to aid physicians
in the identification, evaluation,
treatment, and follow-up of their
patients.
The following elements have been
developed and standardized:

o Referral for bone density
measurement by DEXA (the patient
can choose from four locations)
o Specific biochemical profilingin the
Endocrine Testing Station
o Anthropomorphic meast
;;nts
o Bone biopsy and analysL
· r very
unusual cases only)
o Referral for skin biopsy cu1d
analysis (for suspected osteogenesis
imperfecta)
o Treatment protocols
o A manual of corrective exercises,
impact loading exercises, and ADL
While this is a program of Lehigh
Valley Hospital, it functions as a
private practice model. The Metabolic
Bone Team, namely Dean F. Dimick,
M.D., and Donald E. Barilla, M.D.,
serve as consultants for the patient's
personal physician. This allows
patients to have an expeditious and
cost-effective workup leading to the
correct diagnosis and proper treatment.

Laboratory
Update

JCAHO requires that appropriate
quality control checks be performed
and documented each time an occult
blood is done on a patient. These
checks are the performance monitors
which are part of the slide. Please
record on the chart the patient result as
well as the result of these monitors. A

The program should be viewed as a
resource to allow any physician to care
for his/her patients with bone disease
which will allow for the development
of a large data base and a program that
will be competitive for research funds
and for phase n ·and m drugs. In fact,
the program has already been approved
for the study of a promising third
generation bisphosphonate called
tiludronate.
Bone diseases, both acquired or
genetic, in which the Metabolic Bone
Team has an interest include:

o Osteoporosis (with or without

fractures)

o Juvenil~ osteoporosis
o Steroid-induced osteoporosis

o Osteoporotics from liver disease or
hypercalciuria
o Suspected osteogenesis imperfecti
o The osteomalacias
o Paget's disease
o Parathyroid disorders

To refer a patient or for more
information about the program, please
call402-6786 (402-0STO). Please
direct correspondence to either Dr.
Dimick or Dr. Barilla at the Metabolic
Bone Disease Program, 1210 S. Cedar
Crest Blvd., Suite 1100, Allentown,
PA 18103.
notation such as "QC okay" will

suffice.

If you have any questions regarding
this issue, please contact Sharon L.
Boley, Peripheral/Ancillary Sites
Manager, Health Network
Laboratories, at 402-2552.
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Save Money on Long Distance Telephone Service
through AFFINITY FUND
.
There's a new way to save money on
your long distance telephone service,
both at home and at the office!
Through AFFINITY FUND, a long
distance telephone service provider,
you have the opportunity to realize 535% savings over most readily
available AT&T, MCI, and U.S.
Sprint programs.
.AFFINITY FUND was created to
operate, not alone, but as a partner
with non-profit and charitable
organizations. It relies on the strength
of relationships, which is why it is
called the AFFINITY FUND.

)

you will be pleased with the savings
and quality of service offered by
AFFINITY FUND. Take the time to
compare AFFINITY FUND's long
distance rates to those of your current
canier. You will be pleasantly
surprised!
And, AFFINITY FUND· wiD credit
your account for any fee your local
telephone company may charge you
to switch over.

Through AFFINITY FUND, Lehigh
Valley Hospital, as a non-profit
organization, is offering a unique
program to members of the hospital
family (including members of the
Medical Staff and their employees)
through the auspices of the Lehigh
Valley Hospital Trust Fund.

In a few weeks, you will receive a
letter and a brochure in the mail which
describes in detail how AFFINITY
FUND works. To take advantage of
unbeatable savings and quality service,
simply complete the detachable form in
the brochure and drop it in the mail.
You will also have the satisfaction of
knowing that the charitable aspect of
the program will help fund continuing
education scholarships available to
Lehigh Valley Hospital employees.

After thoroughly checking with other
organizations currently participating in
the program and receiving only
positive feedback, we are confident

If you have any questions about .
AFFINITY FUND, please contact Gail
Evans, Director of Operations,
Development, at (215) 402-3030.

Improper Handling of Syringes/Needles
Legal Services was recently notified by
the Laboratory that private physicians
(both medical and dental) are sending
specimens to the processing lab with
needles attached tO syringes containing
specimens. This practice is both
hazardous to the transporter as well as

the lab employee handling the
specimen.
·
Your cooperation in using a safe and
appropriate method when sending
specimens to the lab is both requested
and appreciated.
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Lehigh Valley DOC

I
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•

Lehigh Valley DOC (Doctors Care), a
local chapter of DOC, is mobilizing
physicians and other concerned citizens
to work toward a tobacco-free society.
DOC is an organization of physicians
and health care professionals interested
in talking to children about the hazards
of smoking. Members of this group
believe that tobacco products are the
leading preventable cause of death and
disability, that second-hand tobacco
smoke is unhealthy, and that the
promotion and sale of tObacco products
to children must be stopped. Activities
of the group will include:
o Identifying how tobacco products
are promoted and supplied in the
Lehigh Valley

o Disseminating this information
o Influencing individuals and groups
to reduce the availability and social
acceptance of tobacco products
o Encouraging tobacco promoters and
suppliers to stop
o Cooperating with other community
agencies concerned aboui tobacco
issues
o Encouraging healthy lifestyles
Your help is needed! Please call Alice
DallaPallu, Program Coordinator,
Coalition for a Smoke-Free Valley, at
402-7460.

New Procedure Offered for Treatment of Dystonia
The use of Botulinum toxin injection
for the treatment of Dystonia,
including Blepharospasm, Hemi-facial
spasm, Torticollis, and limb dystonia is
now available in the Neurophysiology
Laboratory at Lehigh Valley Hospital,
Cedar Crest & 1-78.
Dystonia is a heterogeneous set of
disorders characterized by sustained
muscle contractions causing twisting,
repetitive movements, or postures.
The pathophysiology is obscure.
Botulinum toxin has been found to be
an effective treatment by producing a
clinical denervation when injected into
the affected muscles.

Neurologists Peter J. Barbour, M.D.,
and Robert J. Coni, D. 0., completed
the course in the use of Botulinum
Toxin presented by the Movemenl·
Disorders Group, Neurological Institute
of New York, Columbia-Presbyterian
Medical Center in November. Dr.
Coni received further training through
preceptorship at Albany Medical
School, and Dr. Barbour at the
Graduate Hospital Movement Disorder
Center.
If you have any questions or referrals
for treatment, please contact Dr. Coni
at 366-9160, Dr. Barbour at 402-8420,
or the Neurophysiology Laboratory at
402-8860.
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LIFESAVERS

by Edith J. Gray, R..N., M.S.N., C.E.N., H.P.R..N., Clinical Coordinator/Nurse Specialist, Emergency
Medicine Institute, and Code Blue Committee Member

As is well documented, medications
take second place to other interventions
in a cardiac arrest situation (IAMA,
1992). Proper airway management,
CPR, and electrical therapy, when
indicated, are still the primary concern
for the code team's focus. Once these
interventions are initiated, the code
team personnel can tum to starting an
IV infusion and giving medications.
With any type of venous access delay,
the endotracheal route can and should
be utilized to administer some cardiac
arrest medications. Once the
endotracheal tube has been established
and tube placement is confirmed, the
following drugs can be administered:
)

Oxygen - Lidocaine - Epinephrine Atropine- Narcan (OLEAN)
The newest IAMA recommendations
for the adult patient are that
"medications should be administered at
2-2.5 times the recommended IV dose
and should be diluted in 10ml of
normal saline or distilled water"
(IAMA, 1992, p. 2205). For the
neonatal and pediatric patient, optimal
drug dosages for this route have not
yet been determined (Chameides, 1990
and IAMA, 1992). "Dilution of the
drug into 1-2ml of normal of halfnormal saline may aid drug delivery

into the peripheral airways" (JAMA,
1992, p. 2267). When drugs are
administered via the endotracheal tube,
they should be instilled using a
catheter, or in pediatric and neonatal
patients, an option of utilizing a
feeding tube inserted beyond the distal
tip of the endotracheal tube to promote
maximum absorption froin the
tracheobronchial tree can be utilized.
Another very important factor to
consider while utilizing the
endotracheal medication route, is that
chest compressions should be
withheld during these inssuflations to
aerosolize the medication and to
promote an accelerated and maximum
absorption. The highest possible
oxygen concentration (preferably
100%) should be administered for any
cardiac arrest inssuflation processes.
Thank you for your continued attention
to this month's LIFESAVERS tip!

References:
Chameides, L. et.al. (1990).

Textbook of pediatric advanced life

support. American Heart Association:
Dallas, Texas.
JAMA, (1992). Guidelines for
cardiopulmonary resuscitation and
emergency cardiac care. The Journal
of the American Medical Association

268 (16), 2171-2250.

Tube Feeding Formula Name Change
)

Please be advised that the tube feeding
formula Newtrition HN has been
renamed high nitrogen NITRO~.

Nitrolan will be dispensed to the
nursing units if Newtrition HN is ·
ordered. The formulas are identical
with the exception of the name.
Page 9

Library
News

The Library will be entering into a
project which will result in a
computerized card catalog for both
sites. In an effort to weed out obsolete
books which will not be entered into
the computer, your assistance is
requested in evaluating sections of the
book collections which reflect your
specialty.

Restraint-Free Research
As part of a Pool Trust funded
Restraint-Free Research Study,
beginning April 11, a selected number
of patients will be admitted to specially
engineered rooms on 7B, which were
designed to care for elderly patients
without physically restraining them.
Patients who meet the study criteria
will be asked for consent and then
randomized into study or control

Macy's Day
If you haven't done so already, there is
still time to purchase your ticket for
Macy's Benefit Shopping Day! You
won't want to miss all the excitement
and fun on April 27 when Macy's
hosts this year's benefit shopping day.
In addition to the money saving
coupons you receive with your ticket
purchase, Macy's is planning to offer
many additional discounts on selected
merchandise throughout the day.
Macy's will also be giving away a
number of spectacular prizes in their
Grand Prize Drawing including an
Aruba Dream Vacation for two, a four
day/three night stay at the Kingsbridge
Resort in Williamsburg, Va., a brand
new wardrobe, and much more.

If you are able to provide assistance
with this project, please stop in at
.
either Library location to make
recommendations by June 1. After thA" l
date, the book collections will be
weeded out based on copyright date
and availability of other related
materials in the collections.

groups. Data will be gathered from
both the patient and his or her medical
record daily.
If you decide that participating in the
study is inappropriate for your patient
or for more information about the
study, please contact Carole Moretz,
Manager of Staffing, Nursing
Department, and Principle Investigator,
at pager 3840.

If you're a soap opera fan, you won't
want to miss the chance to meet Linda
Dano who stars as Felicia Gallant on
. NBC's Another World. With her
unique style and flair, Linda will be
showcased at an exciting accessory and
dress fashion show at 7 p.m.

For the sports enthusiasts, Eagles All
Pro punt returner, Vi Sikahema, will

make a personal appearance at 6 p.m.

Tickets are only $5.00 each and the
proceeds will benefit one of three
special programs - Lehigh Valley
Hospice, Friends of Nursing, and the
Transitional Living Center.
For more information, contact the
Lehigh Valley Hospital TruSt Fund at
402-3031.
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Congratulations!
Henry E. Lehrich, M.D., family
practitioner, successfully completed the
necessary continuing education
requirements to retain active
membership in the American Academy
of Family Physicians.

Brian W. Little, M.D., Ph.D.,

neuropathologist, was recently named
to the Executive Committee of the
Pennsylvania Association for Medical
Education for a two-year term.

Publications, Papers and Presentations
George A. arangio, M.D., orthopedic
surgeon, recently published a review of
12 cases of fractures of the fifth
metatarsal bone (the Jones Fracture), in
the November/December issue of the
Journalof Foot & Ankle. The article
compared treating the Jones Fracture
with percutaneous pinning and casting
vs. casting alone.
)

George F. Carr, D.M.D., prostho. dontist, recently presented a lecture for
the University of Pittsburgh Continuing
Education Program in Williamsport.
The topic of the lecture was Creating
a Third Dentition.

Dr. Carr also attended the seminar
Maxillary and Mandibular Bone

Augmentation at the American
College of lmplantology held January
21 and 22 in New Orleans. In
addition, Dr. Carr presented Implant
Dentistry for the 90's for the Joseph
E. Ewing Dental Study Club in
Philadelphia on February 3.

HoushangG. Hamadani, M.D.,

)

psychiatrist, was notified that his
paper, Follow-up of Chlldren on
Ritalin from Chlldhood to
Adolescence was accepted to be
presented at the 9th World Congress of
Psychiatry to be held June 6 to 12 in
Rio de Janeiro, Brazil.

Peter A. Keblish, M.D., chief,
Division of Orthopedic Surgery, was
the author of a major scientific exhibit
and co-author of a second scientific
exhibit at the American Academy of
Orthopaedic Surgeons meeting held in
San Francisco, Calif., in February.
The meeting represents the largest
orthopedic meeting in the world, with
exposure to over 25,000 attendees.
The exhibits concerned the management of the patella in total knee
arthroplasty.
George E. Moerkirk, M.D., chief,
Division of Pre-hospital Emergency
...
Medical Services, presented
Aeromedical Transport of the
Trauma Patient at the Advanced
Emergency Medicine Continuing
Education Program held at the
Philadelphia College of Osteopathic
Medicine on March 10.
John G. Steciw, D.M.D.,
orthodontist, had a case report

published in the January issue of the
American Jounuzl of Orthodontkr and
Dentofacial Otthopedit:r. The case
report documents the multi-phased
treatment of a severe skeletal
malocclusion using functional
orthopedic as well as conventional
fixed appliance therapies.
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Health Promotion/Disease Prevention News
Health Promotion
Program Earns Award
Lehigh Valley Hospital's Health
Promotion and Disease Prevention
Department staff has won the
Pennsylvania Health Educators'
Institute's 1993 Worksite Health
Promotion Award for its creative,
comprehensive programming, and its
access and benefits to employees.
Institutions from across the state with
worksite programs competed for this
annual honor.
Jane Nestor, director, Health
Promotion and Disease Prevention, and
staff members, Sharon Holmes, Judi
Thieme, and David Zimmerman,
accepted the prize at the Institute's
award luncheon in Harrisburg, Pa., on
March 17.
The health promotion/disease
prevention program at Lehigh Valley
Hospital began in 1980, funded by a
grant from the Dorothy Rider Pool
Health Care Trust. The program -offering exercise, smoking cessation,
weight control, and stress management
classes -- is one of the state's largest
health promotion and disease
prevention services for employees and
the community. During the past five
years, 22 percent of the hospital's
5,200 employees have participated in
the program.

Specialty Lectures
The Health Promotion and Disease
Prevention Department of Lehigh
Valley Hospital will present several

free public lectures over the next few
months. Sponsored by the Chronic
Disease Education Committee of
Lehigh Valley Hospital, the lectures
include:
Diabetes: Where We've Been and
Where We're GolD& will be presented
by Larry N. Merkle, M.D., chief,
Division of Endocrinology/Metabolism,
on Tuesday, April27, from 7 to 8:30
p.m., in Classrooms 1 and 2 of Lehigh
Valley Hospital, Cedar Crest & 1-78.

For people with diabetes and their
family, diabetes education is an
essential part of quality care. This
presentation will focus on prevention
issues, c~nt management trends and
treatments, and advances in diabetes
research. This program is cosponsored by the Helwig Diabetes
Center.
)
Dental Implants: A Treatment for
All Ages will be presented by Mark H.
Grim, D.M.D., and Laurence D.
Popowich, D.D.S., oral and
maxillofacial surgeons, and Jack····
Karabasz, D.M.D., prosthodontist, on
Tuesday, May 4, from 7 to 8:30p.m.,
in Classrooms 1 and 2 of Lehigh
Valley Hospital, Cedar Crest & 1-78.

Dental implants are effective, naturallooking, long-term replacements for
missing teeth. The presenters will
discuss causes that can lead to the need
for implants, perspectives of surgical
placement, and the prosthetic
restoration process .. The program will
conclude with ·case presentations and a
question and answer session.
Continued on Page 13
Page 12

Continued from Page 12

Osteoporosis: New lnsi&hts will be

presented by Donald E.~' M.D.,
endocrinologist and supervtsmg
clinician for the Metabolic Bone
Disease Program, on Tuesday, May
11, from 7 to 8:30p.m., in
Classrooms 1 and 2 of Lehigh Valley
Hospital, Cedar Crest & 1-78.
Osteoporosis is one of the most
common skeletal disorders in the
United States, affecting about 25
million Americans. Osteoporosis is
recognized as an important health
problem and researchers continue to
study its causes and current
management. The speaker will provide
new insights regarding prevention of
this disease and share information on
research.

J

What's in the Cart?: Shopsmart - A

dietitian will lead group tours
highlighting low-fat heart healthy food
choices. This will include the new
food groups, convenience food items,
label reading, and special occasion
food selections.
This program will be held on Tuesday,
Apri127, from 9:30 to 11 a.m.,
Wednesday, April 28, from 7 to 8:30
p.m., Monday, May 3, from 9:30 to
11 a.m., and Wednesday; May 5, from
7 to 8:30 p.m., at the Giant Food Store
at 3015 W. Emaus Avenue, Allentown.
The Health Promotion and Disease
Prevention Department also offers
numerous other classes and programs
for weight control, stress management,
and smoking cessation which may
benefit yobr patients. For more
information, call 821-2150.

Upcoming Seminars, Conferences, and Meetings
Symposium Series IV
Renal Transplant: AppHcations for
the Non-Transplant Physician will be

held on Saturday, April24, from 7:45
a.m. to 12:40 p.m., in the Auditorium
of Lehigh Valley Hospital, Cedar Crest
& 1-78.
The number of patients returning to the
general population following successful
solid organ transplant is ever
increasing. With that has come the
challenge for the general internist and
family practitioner to manage a variety
of medical problems that are unique

because of their occurrence in an
immunosuppressed host. Like th~
transplant recipient, there are a ~ety
of other disease states where chrome
immunosuppression is being used more
commonly and similar management
problems may ~se. The objec~~e of
this symposium ts to offer phySICians,
nurses, and other health care
professionals a broad overview of some
of these problems along with practical
solutions.
Continued on Page 14
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Second Annual Wllderness Medicine
Symposium will be held on Saturday,
May 1, from 7:30a.m. to 5:30p.m.,
at Cedar Crest College, 100 College
Drive, Allentown, Pa.
This program will benefit physicians,
nurses, pre-hospital personnel, and
others interested in wilderness
medicine.
At the completion o: ;,his program,
participants should be able to recognize
indications for use of search and rescue
dogs in wilderness rescue, discuss cold
weather survival techniques, recognize
and manage marine envenomations,
recognize and manage a near drowning
victim at the scene and in the hospital,
and make appropriate recommendations
to travelers regarding health and safety
measures.

Thirteenth Annual Update in
Cardioloc will be held on Thursday,
May 6, from 7:45a.m. to 1 p.m., in
the Auditorium of Lehigh Valley
Hospital, Cedar Crest & 1-78.
Physicians and other health
professionals interested in the latest
breakthroughs in selected aspects of
cardiology will benefit from this
program.
At the completion of the program,
participants should be able to discuss
the current applicability of cardiac PET
scanning, describe the state-of-the-art
techniques in nuclear cardiology,
explain the role of MRI in cardiology,
and discuss the role of cardiac
transplantation in the contemporary
treatment of cardiac disease.

For more information on these
programs, contact Human Resource
Development at 402-4609.

J

Medical Grand Rounds
Heparin: Cllnical Use and
Complications will be presented by

Jack Ansell, M.D., Division of
Hematology/Oncology, University of
Massachusetts Medical School,
Worcester, Mass., on Tuesday, April
20.

Insulin Resistance Syndromes will be
presented by Andrea Dunaif, M.D.,
Professor of Medicine and Cellular and
Molecular Biology, and Head of the
Section of Diabetes and Metabolism,
Milton S .. Hershey Medical Center,
Hershey, Pa., on Tuesday, April 27.
Medical Grand Rounds are held on
Tuesday of each week beginning at
noon in the Auditorium of Lehigh
Valley Hospital, Cedar Crest & 1-78.
For more information, contact the
Department of Medicine at 402-8200.

Department of Pediatrics
Common Communication Disorders
in Chlldren will be presented by Mark
Harlor, M.Ed., Division of Pediatric
Speech Pathology, Geisinger Medical
Center, Danville, Pa., on Friday, April
30, at noon, in the Auditorium of
Lehigh Valley Hospital, 17th & Chew.
For more i~· ··,~rmation, contact Beverly
in the Depa.: ~.ment of Pediatrics at
402-2410.
Continued on Page 16

)
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Oncology Program
Psycho-Oncology: Expanding the
Horizons will be held on Wednesday,
April 21, from 8:30a.m. ~ 4 p.m., in
the Auditorium of Lehigh Valley
Hospital, Cedar Crest & 1-78.
This program is devoted to an
exploration of psycho-oncology. The
interdisciplinary approach to
psychosocial cancer care will be
utilized to expand the horizons of
cancer care. Lynna M. Lesko, M.D.,
Ph.D., Assistant Attending Psychiatrist
on the Psychiatry Service at Memorial
Sloan-Kettering Cancer Center will be

• For Sale or Lease - Springhouse
Professional Cent•. 1 676 Pond Road. Ideal
for physlclan"s office. Approximately 2.600
sq. ft. wm finish space to specifications.

PHYaN
PRACltE
OPPORllH11ES

• For Sale or Lease - Medical-professional
office building on South Cedar Crest
Boulevard. just minutes from Cad• Crest It 178 and 17th It Chew. 3.560 total sq. ft.
Ample parking. security/fire 81.-ms Installed.
Ideal for physician group.
• For Sale - Office building at Northeast

This program is intended for
psychiatrists, psychologists, social
workers, nurses, physicians, therapists,
or any health care provider who cares
for individuals or families facing
cancer.
For more information, contact Sandra
Smith, R.N., M.S.N., Director,
Cancer Center, at 402-2582.

• For Lease - Medical office space located In
Southeast Allentown n. . Mountainville
Shopping Cant•.
• For Lease - Slots •• currently available for
the Brown Bag suite at Kutztown Professional
Cant•.
• For Lease - ~· large medical office n. .
Ceder Crest &1-78. Fuly furnished and
staffed. Multiple Hne phone syst.-n.
,I':
Computerized bUHng available.

com.- of 19th and Turner Streets in
AUantown. Upp• laval - 2.400 + sq. ft •• large

• For Lease - Specialty practice time-share
space available In a comprehensive health cere
facllty. Rlv.,.lde Professional Cant•. 4019
Wynnewood Drive. Laurys Station. Half- or
full-day slots Immediately available.

• For Lease - Medical office space located In
Peachtree Office Plaza In Whitehall. One suite
with 1.500 sq. ft. (unfinished - allowance
available). and one 1.000 sq. ft. finished suite.

• For Lease - Sh•e space In MOB 1 on the
c.-npus of Lehigh Valley Hospital. Cad• Crest
& 1-78. Approximately 1.000 sq. ft. Three

ex.-n rooms.

• For Leese - Medical-professional office
space located on Route 222 In WescosvDie.
Two 1.000 sq. ft. offices available or combine
to form lerg.- suite.

For more Information or for assistance In
finding appropriate office space to meat your
needs. contact Joe PUla. POPS Rep. at
402-9856.

waiting room. two l•ge consultation rooms.
five ax.-n rooms. etc. Lower laval - 2.300 +
sq. ft. Parking lot for 16 cars.

)

the featured speaker. Dr. Lesko will
address depression and anxiety in the
cancer patient. Marital issues and
family systems will be the topics for
the remaining general sessions.
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WHO'S NEW
The Who's New section of Medical
Stqff Progress Notes contains an
update of new appointments, address
changes, newly approved privileges,

etc.

Please remember that each department
or unit is responsible for updating its
directory, rolodexes, and approved
privilege rosters.

Medical Staff
Appointments

Joseph A. Habig n, MD

(Southside Family Medicine.- Berkowitz and
Cassel)

141 E. Emaus Avenue
Allentown, PA 18103
(215) 791-5930
Department of Medicine
Division of Family Practice
Provisional Courtesy

Department of Dentistry
Appointments to Division of
Special Care
Russel S. Bleller, Jr., DDS
Department of Dentistry
Division of General Dentistry/Special
Care
Chief, Division of Special Care
Active
Michael P. Borowski, DMD
Department of Dentistry
Division of General Dentistry/Special
Care

Active

Charles J. Incalcaterra, DMD

Department of Dentistry Division of General Dentistry/Special
Care
Active
Michael F. Lentz,_ DDS
Department of Dentistry
Division of General Dentistry/Special
Care
Active
Dominic P. LuDDS
Department of Dentistry
Division of General Dentistry/Special
Care
Active

Shirley A. Nylund, DMD

Department of Dentistry
Division of General Dentistry/Special
Care

Active

JohnS. Ziegler, DDS

Department of Dentistry
·
Division of General Dentistry/Special
Care
Active

J

Appointment of Medical ....
Director
Pediatric Ambulatory Services
Charles F. Smith, MD

Additional Privileges
Mark N. Martz, MD

Department of Surgery
Division of Cardio-thoracic Surgery
Active
Video Assisted Thoracic Surgery &
Thoracoscopy Privileges
Continued on Page 17

)
Page 16

Continued from Page 16

Change of Status
John E. Kenvin, MD
Department of Pediatrics
Division of General Pediatrics
From Consulting to Emeritus
Consulting

Change of Address
Zionsville Family Practice

(R.oaalie R. Snyder, MD, and Kenneth D.
Tl'UICOtt, MD)

·5802 Chestnut Street
Zionsville, PA 18092

New Practice Association
Trachtenberg/Moran
Medicai/Suqical Eye Associates

(W"illiam M. Trachtenberg, MD, and Mark E.

Moran, 00)

1739 Fairmont Street
Allentown, PA 18104
(215) 437-4988

Practice Disassociation and
Address Change

Resignation
Nathan Schwartz, MD

(Lehigh Valley Pain Management • Khan)

Department of Anesthesiology
Provisional Active

Death
Haroun A. Shamai, MD
Department of Medicine
Division of Family Practice
Emeritus Courtesy

Allied Health
Professionals
Resignation
Monica L. Butz, RN
Physician Extender
Professional - RN
(John J. Cassel, MD)

Andrea Weiner, PA
Physician Extender
Physician Assistant

(Panebianco-Yip Heart Surgeons)

Martin D. Misenhimer, MD

(no longer with Family Pediatricians)

281 Cherryville Road
Northampton, PA 18067

Telephone Number Change
Gina Karess, MD
402-2957
Jenni Levy, MD
402-2957
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PHAl\.fiS TRAINING
PHYSICIAN "REFRESHER" SCHEDULE
CEDAR CREST & 1-78

Anderson Wing • Third Floor
Training Room #3

17TH& CHEW
School of Nursing
Training Room (Next to Auditorimn)

Monday, April19

Monday, April 26

Tuesday, April20

Wednesday, April21

Thursday, April 22

Monday, April 26

Wednesday, April 28

7 to 8 a.m.
8:30 to 9:30 a.m.
10 to 11 a.m.
11:30 a.m. to 12:30 p.m.
2 to 3 p.m.
3:30 to 4:30 p.m.
5 to 6 p.m.
7 to 8 a.m.
8:30 to 9:30 a.m.
10 to 11 a.m.
11 a.m. to noon
4 to 5 p.m.
5 to 6 p.m.
6 to 7 p.m.

7 to 8 a.m.
8:30 to 9:30 a.m.
10 to 11 a.m.
11:30 a.m. to 12:30 p.m.
2 to 3 p.m.
3:30 to 4:30 p.m.
5 to 6 p.m.

Tuesday, April 27

Thursday, April 29

9 to 10 a.m.
10 to 11 a.m.

7 to 8 a.m.
8:30 to 9:30 a.m.
10 to 11 a.m.
11:30 a.m. to 12:30 p.m.
2 to 3 p.m.
3:30 to 4:30 p.m.
5 to 6 p.m.
7 to 8 a.m.
8:30 to 9:30 a.m.
. 10 to 11 a.m.
11:30 a.m. to 12:30 p.m.
2 to 3 p.m.
3:30 to 4:30 p.m.
5 to 6 p.m.

noon to 1 p.m.
1:30 to 2:30 p.m.
3 to 4 p.m.
4 to 5 p.m.
5 to 6 p.m.
7 to 8 a.m.
8:30 to 9:30 a.m.
10 to 11 a.m.
11:30 a.m. to 12:30 p.m.
2 to 3 p.m.
3:30 to 4:30 p.m.
s to 6 p.m.
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LEHIGH VALLEY HOSPITAL
VENDOR COMPARISON MATRIX FOR PHYSICIANS

Computerland
George Gamard

Ronl<ave

ex:

Integra
Dale McCandless

MlcroAge.
Marybeth Gdowik

Dell
N/A

481·9000

776·1234

967·4725

434·4301

800·285·1653

IBM
Compaq

BM
Compaq

IBM
Compaq

IBM
Compaq

Dell

$1,394

$1,226

$1,394

$1,290

$1,284

$1,407

$1,407

$1,400

$1,574

$1,346

$1,574

.....
$1,650

$1,524

$1,700

$1,498

$1,600
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LEHIGH VALLEY HOSPITAL
VENDOR COMPARISON MATRIX FOR PHYSICIANS

a:c

MicroAge
Marybeth Gdowik

Dell
N/A

967-4725

434-4301

800-285-1653

IBM

IBM
Compaq

Dell

Ron Kave

Integra
Dale McCandless

481-9000

776-1234

IBM
Compaq

IBM
Compaq

Computertand
George Gamard

...

,•',

··:
·:....

$2,195

$2,350

$2,195

$2,350

$2,098

$2,190

$2,098

$2,300

$2,197

$2,400

$2,348

$2,600

$2,348

$2,600

....·
$2,297

$2,550

::

)

Ptgt 20

LEHIGH VALLEY HOSPITAL
VENDOR COMPARISON MATRIX FOR PHYSICIANS

Computerland
George Gamard

a:c

RonKave

Integra
Dale McCandless

MicroAge ·
Marybeth Gdowik

434·4301

800-285·1653

IBM
Compaq

Dell

481·9000

776-1234

967-4725

IBM
Compaq

IBM

IBM

Compaq

$2,564

$2,515

$2,564

Dell
N/A

$2,1150

$2,517

$2,950

)

)
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LEHIGH VALLEY HOSPITAL
VENDOR COMPARISON MATRIX FOR PHYSICIANS

Additional Hardware/
Software Required

1.

(for remote connections)
2.

Notes:

9600 bps modem • external Hayes Optima available at Integra for $325 and Computerland for $324.

Ungerman Bass network interface cards • supplied by hospital; approx. cost • $300. {for direct connections)

1.

Above prices are estimates based on vendor quotes and catalogues. In addition, the PC market
is currently very volatile. Actual prices may differ from the above quotes depending on current
market drivers.

2.

Vendors will only support quoted prices for 15 days from the time of quote.

3.

All configurations include Microsoft MSDos 5.0 and Windows 3.1.

4.

Delivery and installation charges have NOT been included.

5.

Preferred mouse vendors are: Microsoft, IBM, Logitech.

6.

External modems are preferred - trouble shooting connection problems is easier.

7.

Above vendor's machines have been tested with PHAMIS and the hospital network. Other vendors have
offerings which have not been tested. IS will work with physiciansfoffices to test other vendors as

Actual costs may vary.

needed.

8.

Compaq and IBM computers can also be purchased with Compaq and IBM monitors (instead of Samsung)
for an extra cost of approximately $100 - $150.

9.

Dell prices are from the Feb-Mar 1993 catalogue.

10.

We are currently researching Radio Shack options in addition to those listed above.

)
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LEHJ@iVAILEY
HOSPITAL

P & T Highlights

The following actioos were

taken at the March 8, 1993
P & T Committee meeting.

James A. Giardina, R.Ph.,
Director of Pharmacy

FORMULARY ADDITIONS

Atovaquone (Mepron, BurroughsWellcome) is a newly approved agent

)

indicated as second line therapy for mild
to moderate Pneumocystis carinii
pneumonia (PCP) in patients intolerant of,
or unresponsive to, Co-trimoxazole (TMPSulfa). Atovaquone was originally
synthesized as an antimalarial and works
through blocking pyrimidine biosynthesis.
It's mechanism against PCP is unclear.
Atovaquone is given at a dose of 750mg (3
tablets, 250mg each) three times daily with
food for at least 21 days. Food, and
especially high fat containing foods,
enhance absorption and the manufacturer
cautions that failure to give Atovaquone
with food may result in lower plasma
concentrations and may limit response to
therapy. Parenteral therapy with other
agents should be considered for patients
having difficulty taking food. Due to
limited numbers of patients being treated
with Atovaquone, information on adverse
reactions (ADR) is sparse. Rash is the
most frequent ADR, and it has resolved
spontaneously in some patients. Other
common ADR's include nausea, vomiting,
diarrhea and elevated liver enzymes.
Transient sinus arrhythmia, neutropenia
and an~mia have also been reported.
Weekly monitoring of hematologic, renal
and hepatic function is recommended,
pending further safety information.
Atovaquone is highly protein bound
( > 99.9%). Therefore, caution should
be used when giving it with other highly

protein bound agents with narrow
therapeutic indices. There are no
recommendations for dosage adjustment in
renal or hepatic failure. Atovaquone costs
approximately $19. 00/patient day.

Rifabutin (Mycobutin, Adria) is an

antimycobacterial agent recently approved
for prophylaxis of Mycobacterium Avium
Complex (MAC). Rifabutin (also referred
to as ansamycin in the literature) is
primarily bacteriostatic and may work by
interfering with procaryotic DNAdependent RNA polymerase. Rifabutin
has demonstrated synergy with ethambutol;
but not with clarithromycin. Oral
bioavailability is 12-20% with wide
interpatient variability noted. Repeat dose
studies show induction of drug
metabolizing enzymes, similar to that
which occurs with rifampin. Kinetics,
adverse effects and drug interaction are
also similar to rifampin. Rifabutin causes
all body secretions to tum orange. The
most common ADR's are GI disturbances.
Rifabtitin has caused increases in liver
enzymes. Liver function tests should be
monitored weekly initially, then monthly.
CBC with differential should also be
monitored regularly as thrombocytopenia
and leukopenia have been reported. The
recommended adult dose is 150-300mg
daily, with dosage adjustment in patients
with renal impairment. Rifabutin costs
approximately $3-5/patient day depending
on the dose employed.
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The winner is ...
Amlodipine (Norvasc, Pfizer) is. a

second generation dihydropyridine calcium
channel blocker, related to the current
formulary agents - nifedipine, nicardipine
and isradapine. Amlodipine is indicated in
the treatment of hypertension, chronic
stable angina and vasospastic angina.
Amlodipine has both a gradual onset (5-30
minutes) and a long duration of action,
which distinguishes it from other
dihydropyridines. Like other
.
dihydropyridines, amlodipine has minima]
negative inotropic activity at high
concentrations (less than nifedipine). The
following table compares Amlodipine to
Isradapine (Dynacirc) and Felodipine
(Plendil). Isradapine was previously added
to the formulary and Felodipine was
denied formulary inclusion.

Adverse Drug Reactions include mild to
moderate edema, nausea, fatigue, headache
and flushing. Few side effects are seen
with 5mg doses, and the incidence
increases with increasing doses, especially
above lOmg. Because of its gradual onset,
acute vasodilator-related side effects are
lower than with other dihydropyridine
agents. Like other dihydropyridines,
Amlodipine causes fewer cardiac .
conduction disturbances, bradycardia, or
constipation than either diltiazem or
verapamil. To date, there are no known
drug interactions. Amlodipine's usual
dose is 5-lOmg given once daily. Doses
up to 20mg have been used. Dosage
adjustment in renal failure is unnecessary,
however, elderly and liver impaired
patients may requ~ a lower dose.
Amlodipine costs $0.90/5mg tablet.

) .

TABLE 1: Comparison of Various Dihydropyridine Calcium Channel Blockers
Generic
Trade Name
Manufacturer
Pharmacokinetics
Bioavailability
Peak Level (PO)
Half Life
Protein Binding
Metabolism

Amlodipine
Norvasc
Pftzer

Felodipine
Plendil
MSD

Isradipine
Dynacirc
Sandoz

52-88%
5.6-7h
31.2-48h
97-99%
Hepatic

Active Metabolites
Drug Interactions
Dosage Adjustment
Elderly
Hepatic Disease
Renal Dysfunction
Starting Dose
Frequency
Cost/Day

No
No

20%
4-5h
10-17h
99%
Hepatic
First Pass
No
Yes

19-24%
2h
8-9.6h
98%
Hepatic/Bile
First Pass
No
No

Yes
Yes
No
5mg
QD
$0.89

Yes
Yes
No
5mg
QD
$0.71

Yes
Yes
No
2.5mg
BID
$0.80
)
Page 24

And the winner isn't...

Drug Use Evaluation

Felodipine (Plendil, Merck) was

Tora, Tora, Toradol!

also discussed at the same time as
Amlodipine. Felodipine has more
vasodilatory effects than Amlodipine, and
is more likely to have drug interactions
given its extensive metabolism by the
Cytochrome P-450 system. Felodipine
was rejected for formulary addition.

Results of a study of Ketorolac injection
(Toradol, Syntex) usage were discussed.
66 patients were reviewed. Key fmdings

are:

The Committee agreed to again revisit
usage of this class of agen~ in six months.

Met criteria
Criteria
51%
Appropriate dosage
80%
Maximum dosage
Therapy discontinuation 75%

For your information, Ketorolac should be used as follows:
Loading Dose:

30 or 60mg 1M or IV

Maintenance Dose:

50% of loading_ dose 1M or IV Q6H on regular schedule or on
an as needed basis. Dose adjustment should be made for patients
> 65 years old; < 50Kg; Renal dysfunction.

Max. Daily Dose:

Not more than 150mg on day one and 120mg thereafter.

Contraindications:

Those typical of Prostaglandin inhibitors.

Length of Therapy: Ketorolac should be discontinued once patients are able to
tolerate oral therapy or up to 48 hours postoperatively.

Editor's Note:

Ketorolac may be given IV push over 5 minutes when in the
Physician's judgement it may be advantageous. This route has
not yet been approved by the FDA. There is considerable data
demonstrating the safety of IV administration and the
manufacturer is awaiting FDA approval to include this route in
the package insert.

Given the opportunities for improvement, focused educational efforts will be made and usage
will be restudied. A 5 day auto stop order with physician notice was approved.
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Ped-Ophylline DUE
Pediatric Intravenous Theophylline Therapy was also discussed. Key findings in this study
of 34 patients were:
Criteria
Loading dose
Initial hourly infusion

Criteria met
89%
56%

Serum Therapeutic Concentrations (STC)
STC within usual range
Post bolus level at appropriate time
Level within 8 hours
Level within 24 hours
Adverse effects experienced

33%
50%
41%
94%
53%

Suggested monitoring guidelines were also discussed. Once the guidelines are approved by
Pediatrics, IV Theophylline patients will be restudied to assess improvement.

No V.O. for CA

New Policy on Verbal/Telephm··
Orders for Chemotherapy Mec
for Cancer Patients

The Committee approved a new policy
prohibiting the ordering or changing of
cancer chemotherapy meds by any means
other than in writing. Clarification and
discontinuation orders will be allowed to
be given via the verbal or telephone
process. This policy is in response to
significant medication errors which have
been reported in the press and errors
which were potentially serious within our
system. On a related matter, the
Committee was also reminded that the use
of abbreviations, while convenient to the
Prescriber, (and authors) can contribute to
medication errors. The hospital list of
approved abbreviations only contains
abbreviations for medications whose
generic name equals their chemical name
(KCL, NTG, etc.) Abbreviations are
easily misread, misinterpreted and are
generally not easily located in standard
reference texts, given that most texts don't
index by abbreviation.

Target Antibiotics

The Committee reviewed the January,
1993 results. A separate article outlining
areas of concern as well as suggested
appropriate usage is presented in this
issue.

Page 28

Additions to Nursing IV
Guidelines
The Nursing IV guidelines were updated
as follows:
Bum.etanide

- added to guidelines

Furosemide

- revised guidelines relative
to rate of administration

Lorazepam*

- addition of information
(concentration, stability,
dose) for IV infusions; IV
infusion is restricted to
Critical Care

Midazolam

- revised guidelines relative
to rate of administration

Editor's Note: * As with several other
medications, the official FDA approved
references (package insert, PDR, etc) do
not contain information on IV infusion.
There is limited data available which does
support this use in certain clinical
situations - consult the Clinical Pharmacy
Service (Ext. 8884 (CC); Ext. 2796 (17)
for more information.

If your Broker hasn 't cfl},led
lately or who's Bullish on
Biotech now?
Interleukin 1 - receptor antagonist (IL-l ra
Antril, Synergen) appears to· be the latest
casualty in the biotech battle to get an
indication for septic shock. Preliminary
analysis of the most recent trial showed
only a 15% improvement versus placebo.
IL-lra was rumored to cost $3000 per
treatment. If you haven't heard yet,
Centocor, manufacturer of Nebacum.ab
(HA-lA, Centoxin) suspended trials and
European sales of its new drug recently,
also due to negative outcomes on its most
recent trial in septic shock patients.

...

:

)
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Update on Antibiotic Prescribing Practices at L VH
The Clinical Pharmacy l)epartment, in conjunction with Infectious Diseases, would like to take
this time to update our review of the antibiotic prescribing practices over the past six months.
Five antibiotics are being targeted for review and include: ceftazidime, IV ciprofloxacin,
ceftriaxone, ampicillin/sulbactam, and aztreonam. The review criteria are based on the usage
guidelines printed on the back of the parenteral antibiotic order sheet (P AOS).
The drug-use-evaluation results have remained fairly consistent over the six month period.
Improvements have been seen in two specific areas. Initially, ceftriaxone was being
inappropriately dosed at a Q12H interval for 25% of patients regardless of age or site of
infection. It is now being dosed more appropriately with a Q24 hour interval for almost all
non-CNS and non-pediatric patients. The use of aztreonam has also improved in accordance
with the approved usage guidelines.

Areas of concern include the high percentage of empiric use of both ceftazidime and IV
ciprofloxacin. The suggested usage guidelines for ceftazidime recommend its use for aerobic
gram-negative bacilli resistant to cefazolin (ie. Enterobacter or Serratia) at dosages of 1Gm
IV Q8H: and Pseudomonas aeruginosa at dosages of 2Gm IV Q8H, when piperacillin is not
appropriate (allergy or resistance). IV ciprofloxacin use should be limited to resistant
aerobic gram-negative bacilli based on the patient's culture and susceptibility results. Therapy
may be initiated intravenously with oral therapy instituted as soon as clinically feasible.
Ciprofloxacin, or any quinolone, should not be used if a Staph, Strep, or an anaerobe is the
only suspected pathogen.
The use of claritbromycin (Biaxin), a new oral macrolide, has also increased within the
institution. Keep in mind, clarithromycin should be used when monotherapy with erythromycin
is not feasible (ie. intolerance, infection secondary to concurrent multiple pathogens in COPD,
or M. Avium).
If ciprofloxacin therapy is warranted, prompt streamlining to oral therapy offers an effective
alternative to parenteral therapy. Currently, the average length of therapy for IV ciprofloxacin
is approximately 4.0 days with empiric therapy, and 5.0 days for UTI's. Equivalent serum and
tissue concentrations are achieved with both oral and parenteral therapy. An active Cipro IV
to PO campaign has begun by the Clinical Pharmacy Department in order to encourage
physicians to consider oral therapy.
Piperacillin +/- an aminoglycoside is a good frrst-line empiric therapy option for the nonpenicillin allergic patient. The hospital-wide isolates, especially the Proteus, Pseudomonas, and
Serratia isolates, remain highly susceptible to piperacillin (91-98%). In addition, Enterobacter
isolates are very susceptible to and cail be treated with agents such as
trimethoprim/sulfamethoxazole or an aminoglycoside (gentamicin, or tobramycin).
Monitoring of the parenteral antibiotic prescribing practices will be continued on a monthly
basis. We are asking for everyone's cooperation with adhering to the antibiotic usage
guidelines, tailoring empiric therapy promptly, and considering oral therapy as soon as feasible.
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